Baystate Wealth Management’s CRISPR Therapeutics CRSP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$3.82K Hold
61
﹤0.01% 944
2023
Q3
$2.77K Hold
61
﹤0.01% 767
2023
Q2
$3.43K Hold
61
﹤0.01% 767
2023
Q1
$2.76K Buy
+61
New +$2.76K ﹤0.01% 787
2020
Q4
Sell
-14
Closed -$1K 691
2020
Q3
$1K Sell
14
-130
-90% -$9.29K ﹤0.01% 573
2020
Q2
$11K Buy
+144
New +$11K ﹤0.01% 374